Ensuring Global Access to LP-284

In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, talks about ensuring global access to LP-284, particularly in regions with limited resources

Leave a Reply

Your email address will not be published. Required fields are marked *